MENU
+Compare
EVGN
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$1.34
Change
-$0.02 (-1.47%)
Capitalization
11.56M

EVGN Evogene Ltd. Forecast, Technical & Fundamental Analysis

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications... Show more

Industry: #Biotechnology
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EVGN with price predictions
Jul 03, 2025

Momentum Indicator for EVGN turns negative, indicating new downward trend

EVGN saw its Momentum Indicator move below the 0 level on June 25, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned negative. In of the 95 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EVGN moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for EVGN turned negative on June 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EVGN broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

EVGN moved above its 50-day moving average on June 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EVGN crossed bullishly above the 50-day moving average on June 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EVGN advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 128 cases where EVGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.834) is normal, around the industry mean (16.666). P/E Ratio (0.304) is within average values for comparable stocks, (58.763). EVGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.213) is also within normal values, averaging (269.614).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EVGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVGN is expected to report earnings to rise 59.21% to -60 cents per share on August 06

Evogene Ltd. EVGN Stock Earnings Reports
Q2'25
Est.
$-0.61
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.66
Q3'24
Missed
by $0.30
Q2'24
Beat
by $0.19
The last earnings report on May 21 showed earnings per share of -37 cents, beating the estimate of -73 cents. With 44.79K shares outstanding, the current market capitalization sits at 11.56M.
A.I. Advisor
published General Information

General Information

a developer of plant traits for the agriculture and biofuel industries

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13 Gad Feinstein Street
Phone
+972 89311900
Employees
142
Web
https://www.evogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSET16.100.46
+2.94%
Bassett Furniture Industries
LPLA384.117.64
+2.03%
LPL Financial Holdings
DORM128.090.78
+0.61%
Dorman Products
SIBN18.470.04
+0.22%
SI-BONE
ACXP0.48N/A
-0.97%
Acurx Pharmaceuticals

EVGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EVGN has been loosely correlated with CARM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EVGN jumps, then CARM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
-1.47%
CARM - EVGN
58%
Loosely correlated
-4.05%
INSM - EVGN
32%
Poorly correlated
N/A
PMVP - EVGN
31%
Poorly correlated
+8.18%
AXON - EVGN
30%
Poorly correlated
+2.70%
FATE - EVGN
29%
Poorly correlated
N/A
More